|
1
|
Baena R and Salinas P: Diet and colorectal
cancer. Maturitas. 80:258–264. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lippi G, Mattiuzzi C and Cervellin G: Meat
consumption and cancer risk: A critical review of published
meta-analyses. Crit Rev Oncol Hematol. 97:1–14. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Keshk WA, Zineldeen DH, Wasfy RE and
El-Khadrawy OH: Fatty acid synthase/oxidized low-density
lipoprotein as metabolic oncogenes linking obesity to colon cancer
via NF-kappa B in Egyptians. Med Oncol. 31:1922014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Davis-Yadley AH, Lipka S, Shen H, Devanney
V, Swarup S, Barnowsky A, Silpe J, Mosdale J, Pan Q, Fridlyand S,
et al: Ethnic disparities in the risk of colorectal adenomas
associated with lipid levels: A retrospective multiethnic study. J
Gastrointest Cancer. 46:29–35. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Reverter M, Rentero C, Garcia-Melero A,
Hoque M, Vilà de Muga S, Alvarez-Guaita A, Conway JR, Wood P,
Cairns R, Lykopoulou L, et al: Cholesterol regulates Syntaxin 6
trafficking at trans-Golgi network endosomal boundaries. Cell Rep.
7:883–897. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sheng R, Kim H, Lee H, Xin Y, Chen Y, Tian
W, Cui Y, Choi JC, Doh J, Han JK, et al: Cholesterol selectively
activates canonical Wnt signalling over non-canonical Wnt
signalling. Nat Commun. 5:43932014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nielsen SF, Nordestgaard BG and Bojesen
SE: Statin use and reduced cancer-related mortality. N Engl J Med.
367:1792–1802. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Poynter JN, Gruber SB, Higgins PD, Almog
R, Bonner JD, Rennert HS, Low M, Greenson JK and Rennert G: Statins
and the risk of colorectal cancer. N Engl J Med. 352:2184–2192.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lytras T, Nikolopoulos G and Bonovas S:
Statins and the risk of colorectal cancer: An updated systematic
review and meta-analysis of 40 studies. World J Gastroenterol.
20:1858–1870. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xiao H and Yang CS: Combination regimen
with statins and NSAIDs: A promising strategy for cancer
chemoprevention. Int J Cancer. 123:983–990. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xiao H, Zhang Q, Lin Y, Reddy BS and Yang
CS: Combination of atorvastatin and celecoxib synergistically
induces cell cycle arrest and apoptosis in colon cancer cells. Int
J Cancer. 122:2115–2124. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang Z, Xiao H, Jin H, Koo PT, Tsang DJ
and Yang CS: Synergistic actions of atorvastatin with
gamma-tocotrienol and celecoxib against human colon cancer HT29 and
HCT116 cells. Int J Cancer. 126:852–863. 2010.PubMed/NCBI
|
|
13
|
Lu G, Xiao H, You H, Lin Y, Jin H,
Snagaski B and Yang CS: Synergistic inhibition of lung
tumorigenesis by a combination of green tea polyphenols and
atorvastatin. Clin Cancer Res. 14:4981–4988. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bazzano LA, Serdula MK and Liu S: Dietary
intake of fruits and vegetables and risk of cardiovascular disease.
Curr Atheroscler Rep. 5:492–499. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu RH: Health benefits of fruit and
vegetables are from additive and synergistic combinations of
phytochemicals. Am J Clin Nutr. 78(3 Suppl): 517S–520S.
2003.PubMed/NCBI
|
|
16
|
Boyer J and Liu RH: Apple phytochemicals
and their health benefits. Nutr J. 3:52004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hyson DA: A comprehensive review of apples
and apple components and their relationship to human health. Adv
Nutr. 2:408–420. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kobori M, Iwashita K, Shinmoto H and
Tsushida T: Phloretin-induced apoptosis in B16 melanoma 4A5 cells
and HL60 human leukemia cells. Biosci Biotechnol Biochem.
63:719–725. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Iwashita K, Kobori M, Yamaki K and
Tsushida T: Flavonoids inhibit cell growth and induce apoptosis in
B16 melanoma 4A5 cells. Biosci Biotechnol Biochem. 64:1813–1820.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Park SY, Kim EJ, Shin HK, Kwon DY, Kim MS,
Surh YJ and Park JH: Induction of apoptosis in HT-29 colon cancer
cells by phloretin. J Med Food. 10:581–586. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu CH, Ho YS, Tsai CY, Wang YJ, Tseng H,
Wei PL, Lee CH, Liu RS and Lin SY: In vitro and in vivo study of
phloretin-induced apoptosis in human liver cancer cells involving
inhibition of type II glucose transporter. Int J Cancer.
124:2210–2219. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang KC, Tsai CY, Wang YJ, Wei PL, Lee CH,
Chen JH, Wu CH and Ho YS: Apple polyphenol phloretin potentiates
the anticancer actions of paclitaxel through induction of apoptosis
in human hep G2 cells. Mol Carcinog. 48:420–431. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chou TC and Talalay P: Quantitative
analysis of dose-effect relationships: The combined effects of
multiple drugs or enzyme inhibitors. Adv Enzyme Regul. 22:27–55.
1984. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gazzerro P, Proto MC, Gangemi G, Malfitano
AM, Ciaglia E, Pisanti S, Santoro A, Laezza C and Bifulco M:
Pharmacological actions of statins: A critical appraisal in the
management of cancer. Pharmacol Rev. 64:102–146. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang EH, Johnson LA, Eaton K, Hynes MJ,
Carpentino JE and Higgins PD: Atorvastatin induces apoptosis in
vitro and slows growth of tumor xenografts but not polyp formation
in MIN mice. Dig Dis Sci. 55:3086–3094. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Athyros VG, Tziomalos K, Karagiannis A and
Mikhailidis DP: Atorvastatin: Safety and tolerability. Expert Opin
Drug Saf. 9:667–674. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gray RT, Loughrey MB, Bankhead P, Cardwell
CR, McQuaid S, O'Neill RF, Arthur K, Bingham V, McGready C, Gavin
AT, et al: Statin use, candidate mevalonate pathway biomarkers and
colon cancer survival in a population-based cohort study. Br J
Cancer. 116:1652–1659. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Voorneveld PW, Reimers MS, Bastiaannet E,
Jacobs RJ, van Eijk R, Zanders MMJ, Herings RMC, van Herk-Sukel
MPP, Kodach LL, van Wezel T, et al: Statin use after diagnosis of
colon cancer and patient survival. Gastroenterology.
153:470–479.e4. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ishikawa S, Hayashi H, Kinoshita K, Abe M,
Kuroki H, Tokunaga R, Tomiyasu S, Tanaka H, Sugita H, Arita T, et
al: Statins inhibit tumor progression via an enhancer of zeste
homolog 2-mediated epigenetic alteration in colorectal cancer. Int
J Cancer. 135:2528–2536. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Evan GI and Vousden KH: Proliferation,
cell cycle and apoptosis in cancer. Nature. 411:342–348. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fisher D, Krasinska L, Coudreuse D and
Novák B: Phosphorylation network dynamics in the control of cell
cycle transitions. J Cell Sci. 125:4703–4711. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chow JP and Poon RY: The CDK1 inhibitory
kinase MYT1 in DNA damage checkpoint recovery. Oncogene.
32:4778–4788. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhan Q, Antinore MJ, Wang XW, Carrier F,
Smith ML, Harris CC and Fornace AJ Jr: Association with Cdc2 and
inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated
protein Gadd45. Oncogene. 18:2892–2900. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dash BC and El-Deiry WS: Phosphorylation
of p21 in G2/M promotes cyclin B-Cdc2 kinase activity. Mol Cell
Biol. 25:3364–3387. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lin YC, Lin JH, Chou CW, Chang YF, Yeh SH
and Chen CC: Statins increase p21 through inhibition of histone
deacetylase activity and release of promoter-associated HDAC1/2.
Cancer Res. 68:2375–2383. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mohammed A, Qian L, Janakiram NB,
Lightfoot S, Steele VE and Rao CV: Atorvastatin delays progression
of pancreatic lesions to carcinoma by regulating PI3/AKT signaling
in p48Cre/+ LSL-KrasG12D/+ mice. Int J Cancer. 131:1951–1962. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Buranrat B, Senggunprai L, Prawan A and
Kukongviriyapan V: Simvastatin and atorvastatin as inhibitors of
proliferation and inducers of apoptosis in human cholangiocarcinoma
cells. Life Sci. 153:41–49. 2016. View Article : Google Scholar : PubMed/NCBI
|
